Thermo Fisher Scientific, AbbVie, Bloom Energy, Vertex Pharmaceuticals, Danaher, Lumentum, and Fabrinet are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that use biological processes, living organisms or molecular biology techniques to develop products and technologies in health care, agriculture and environmental sectors. Investors in these stocks typically seek high-growth opportunities driven by breakthroughs in drug discovery, genetic engineering and diagnostic tools, while accepting elevated volatility and regulatory risk. These companies had the highest dollar trading volume of any Biotech stocks within the last several days.
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Shares of TMO stock traded up $3.44 during trading hours on Friday, hitting $488.48. 955,412 shares of the company's stock were exchanged, compared to its average volume of 2,487,897. The company has a current ratio of 1.93, a quick ratio of 1.50 and a debt-to-equity ratio of 0.65. Thermo Fisher Scientific has a 12-month low of $385.46 and a 12-month high of $627.88. The business's 50 day simple moving average is $433.08 and its 200-day simple moving average is $461.44. The company has a market capitalization of $184.45 billion, a PE ratio of 28.24, a PEG ratio of 2.59 and a beta of 0.74.
Read Our Latest Research Report on TMO
AbbVie (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.
Shares of NYSE:ABBV traded up $0.85 during midday trading on Friday, reaching $205.53. The company's stock had a trading volume of 1,678,167 shares, compared to its average volume of 6,692,263. The firm has a 50 day moving average of $190.74 and a 200-day moving average of $191.86. The firm has a market capitalization of $363.07 billion, a P/E ratio of 97.86, a PEG ratio of 1.29 and a beta of 0.50. The company has a quick ratio of 0.61, a current ratio of 0.74 and a debt-to-equity ratio of 44.14. AbbVie has a 12-month low of $163.81 and a 12-month high of $218.66.
Read Our Latest Research Report on ABBV
Bloom Energy (BE)
Bloom Energy Corporation designs, manufactures, sells, and installs solid-oxide fuel cell systems for on-site power generation in the United States and internationally. The company offers Bloom Energy Server, a solid oxide technology that converts fuel, such as natural gas, biogas, hydrogen, or a blend of these fuels into electricity through an electrochemical process without combustion.
Bloom Energy stock traded up $0.21 during mid-day trading on Friday, reaching $45.32. The stock had a trading volume of 5,788,736 shares, compared to its average volume of 7,213,800. The company has a market capitalization of $10.60 billion, a price-to-earnings ratio of 1,133.28 and a beta of 3.28. The company has a 50-day moving average price of $28.10 and a two-hundred day moving average price of $23.36. Bloom Energy has a one year low of $9.02 and a one year high of $46.50. The company has a debt-to-equity ratio of 2.18, a current ratio of 4.99 and a quick ratio of 3.21.
Read Our Latest Research Report on BE
Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor.
VRTX traded up $3.41 during midday trading on Friday, hitting $393.71. 558,198 shares of the company traded hands, compared to its average volume of 1,645,172. The firm has a market capitalization of $100.94 billion, a PE ratio of 28.15 and a beta of 0.44. The company's 50-day moving average is $446.11 and its 200 day moving average is $464.11. Vertex Pharmaceuticals has a 52 week low of $362.50 and a 52 week high of $519.88.
Read Our Latest Research Report on VRTX
Danaher (DHR)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Shares of NYSE DHR traded up $0.68 during midday trading on Friday, hitting $210.90. 933,768 shares of the company's stock traded hands, compared to its average volume of 4,231,161. Danaher has a 1 year low of $171.00 and a 1 year high of $279.90. The stock has a market capitalization of $151.01 billion, a price-to-earnings ratio of 44.85, a price-to-earnings-growth ratio of 2.92 and a beta of 0.73. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The firm has a fifty day moving average of $199.64 and a 200 day moving average of $200.12.
Read Our Latest Research Report on DHR
Lumentum (LITE)
Lumentum Holdings Inc. manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company operates through two segments: Optical Communications (OpComms) and Commercial Lasers (Lasers). The OpComms segment offers components, modules, and subsystems that enable the transmission and transport of video, audio, and data over high-capacity fiber optic cables.
Shares of NASDAQ LITE traded up $0.20 during midday trading on Friday, hitting $114.82. 1,338,276 shares of the company's stock traded hands, compared to its average volume of 2,575,093. Lumentum has a 1 year low of $45.65 and a 1 year high of $129.98. The stock has a market capitalization of $7.97 billion, a price-to-earnings ratio of 502.03 and a beta of 1.33. The company has a debt-to-equity ratio of 2.26, a quick ratio of 3.53 and a current ratio of 4.37. The firm has a fifty day moving average of $97.91 and a 200 day moving average of $78.58.
Read Our Latest Research Report on LITE
Fabrinet (FN)
Fabrinet provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe. The company offers a range of advanced optical and electro-mechanical capabilities in the manufacturing process, including process design and engineering, supply chain management, manufacturing, printed circuit board assembly, advanced packaging, integration, final assembly, and testing.
Fabrinet stock traded up $4.87 during midday trading on Friday, hitting $326.95. The stock had a trading volume of 381,479 shares, compared to its average volume of 706,786. The firm's fifty day moving average is $294.80 and its two-hundred day moving average is $239.08. The company has a market capitalization of $11.71 billion, a PE ratio of 36.41 and a beta of 1.02. Fabrinet has a 52-week low of $148.55 and a 52-week high of $356.55.
Read Our Latest Research Report on FN
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Thermo Fisher Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.
While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
MarketBeat All Access